Mercer Global Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.49M Sell
16,846
-1,096
-6% -$297K 0.01% 803
2025
Q4
$4.5M Sell
17,942
-426
-2% -$113K 0.01% 754
2025
Q3
$5.27M Sell
18,368
-547
-3% -$147K 0.01% 650
2025
Q2
$4.97M Buy
18,915
+148
+0.8% +$36K 0.01% 568
2025
Q1
$4.37M Sell
18,767
-511
-3% -$124K 0.01% 582
2024
Q4
$4.42M Sell
19,278
-4,581
-19% -$1.05M 0.01% 577
2024
Q3
$5.23M Sell
23,859
-24,865
-51% -$5.47M 0.01% 491
2024
Q2
$9.92M Sell
48,724
-1,758
-3% -$358K 0.03% 306
2024
Q1
$11M Buy
50,482
+2,236
+5% +$493K 0.03% 293
2023
Q4
$11M Buy
48,246
+4,511
+10% +$948K 0.03% 290
2023
Q3
$8.79M Sell
43,735
-1,252
-3% -$264K 0.03% 300
2023
Q2
$9.33M Buy
44,987
+732
+2% +$142K 0.04% 310
2023
Q1
$8.72M Buy
44,255
+3,096
+8% +$637K 0.04% 296
2022
Q4
$8.33M Sell
41,159
-1,052
-2% -$206K 0.04% 308
2022
Q3
$7.43M Buy
42,211
+95
+0.2% +$19.4K 0.04% 287
2022
Q2
$8.48M Buy
42,116
+2,284
+6% +$487K 0.05% 254
2022
Q1
$9.02M Buy
39,832
+5,138
+15% +$1.21M 0.05% 247
2021
Q4
$9.37M Buy
34,694
+1,812
+6% +$449K 0.06% 247
2021
Q3
$7.95M Buy
32,882
+7,317
+29% +$1.84M 0.06% 266
2021
Q2
$6.06M Buy
25,565
+8,706
+52% +$1.98M 0.05% 287
2021
Q1
$3.69M Buy
16,859
+647
+4% +$130K 0.03% 363
2020
Q4
$2.83M Buy
16,212
+874
+6% +$151K 0.04% 348
2020
Q3
$2.48M Sell
15,338
-475
-3% -$75.3K 0.04% 328
2020
Q2
$2.26M Sell
15,813
-1,116
-7% -$154K 0.04% 301
2020
Q1
$1.84M Buy
16,929
+2,124
+14% +$306K 0.04% 332
2019
Q4
$2.15M Buy
14,805
+426
+3% +$61.5K 0.04% 322
2019
Q3
$2.08M Buy
14,379
+844
+6% +$123K 0.05% 301
2019
Q2
$2.01M Buy
13,535
+2,534
+23% +$354K 0.05% 284
2019
Q1
$1.45M Buy
+11,001
New +$1.36M 0.05% 311

Other funds holding LH

Mercer Global Advisors's LH Position: Q1 2026 in Review

Mercer Global Advisors reduced its Labcorp (LH) stake by 6.1% in Q1 2026, selling an estimated $297K and leaving 16,846 shares worth $4.49M. The position accounts for 0.01% of the portfolio, ranked #803.

Mercer Global Advisors first reported a position in LH in Q1 2019 and has held it in 29 quarters since. The position peaked at $11M in Q1 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Mercer Global Advisors held 16,846 shares of Labcorp worth $4.49M as of Q1 2026.
  • Mercer Global Advisors sold 1,096 Labcorp shares in Q1 2026, an estimated $297K.
  • Labcorp made up 0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #803 holding.
  • Mercer Global Advisors first reported a position in Labcorp in Q1 2019 and has held it in 29 quarters since.
  • Mercer Global Advisors's Labcorp position peaked at $11M in Q1 2024.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.